{"id":"https://openalex.org/W2016359652","doi":"https://doi.org/10.1081/dmr-120001387","title":"Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes","display_name":"Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2016359652","doi":"https://doi.org/10.1081/dmr-120001387","mag":"2016359652","pmid":"https://pubmed.ncbi.nlm.nih.gov/11996009"},"language":"en","primary_location":{"id":"doi:10.1081/dmr-120001387","doi":"https://doi.org/10.1081/dmr-120001387","is_oa":false,"landing_page_url":"https://doi.org/10.1081/dmr-120001387","pdf_url":null,"source":{"id":"https://openalex.org/S133743172","display_name":"Drug Metabolism Reviews","issn_l":"0360-2532","issn":["0360-2532","1097-9883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016359652"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025474639","display_name":"Paul F. Hollenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul F. Hollenberg","raw_affiliation_strings":["The University of Michigan, Ann Arbor, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Michigan, Ann Arbor, USA","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5025474639"],"corresponding_institution_ids":["https://openalex.org/I27837315"],"apc_list":null,"apc_paid":null,"fwci":0.7514,"has_fulltext":false,"cited_by_count":285,"citation_normalized_percentile":{"value":0.57971014,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"34","issue":"1-2","first_page":"17","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11747","display_name":"Metal-Catalyzed Oxygenation Mechanisms","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.9599999785423279},{"id":"https://openalex.org/keywords/enzyme-inhibitors","display_name":"enzyme inhibitors","score":0.7260000109672546},{"id":"https://openalex.org/keywords/enzyme-inducers","display_name":"enzyme inducers","score":0.9520000219345093},{"id":"https://openalex.org/keywords/enzyme-activators","display_name":"enzyme activators","score":0.9309999942779541},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.6399999856948853},{"id":"https://openalex.org/keywords/enzyme-modulation","display_name":"enzyme activity modulation","score":0.3580000102519989},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.7838165760040283},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.7503727674484253},{"id":"https://openalex.org/C2225953","wikidata":"https://www.wikidata.org/wiki/Q1661899","display_name":"Inducer","level":3,"score":0.6689066290855408},{"id":"https://openalex.org/C132154277","wikidata":"https://www.wikidata.org/wiki/Q5381545","display_name":"Enzyme inducer","level":3,"score":0.653303861618042},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5454642176628113},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5232045650482178},{"id":"https://openalex.org/C50605568","wikidata":"https://www.wikidata.org/wiki/Q14912267","display_name":"CYP2B6","level":5,"score":0.5084878206253052},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40783563256263733},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2899389863014221},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.2379518449306488},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09500953555107117}],"mesh":[{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020536","descriptor_name":"Enzyme Activators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1081/dmr-120001387","doi":"https://doi.org/10.1081/dmr-120001387","is_oa":false,"landing_page_url":"https://doi.org/10.1081/dmr-120001387","pdf_url":null,"source":{"id":"https://openalex.org/S133743172","display_name":"Drug Metabolism Reviews","issn_l":"0360-2532","issn":["0360-2532","1097-9883"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism Reviews","raw_type":"journal-article"},{"id":"pmid:11996009","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11996009","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism reviews","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.902.9786","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.902.9786","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://www.researchgate.net/profile/Paul_Hollenberg/publication/11374657_Characteristics_and_common_properties_of_inhibitors_inducers_and_activators_of_CYP_enzymes/links/0fcfd50bdedec9f28f000000.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":66,"referenced_works":["https://openalex.org/W23768266","https://openalex.org/W39142732","https://openalex.org/W40096266","https://openalex.org/W360731194","https://openalex.org/W1008229810","https://openalex.org/W1503367288","https://openalex.org/W1504223539","https://openalex.org/W1505278126","https://openalex.org/W1511387305","https://openalex.org/W1514057210","https://openalex.org/W1525055187","https://openalex.org/W1557236062","https://openalex.org/W1571762463","https://openalex.org/W1576919957","https://openalex.org/W1577296862","https://openalex.org/W1578271139","https://openalex.org/W1579040796","https://openalex.org/W1592099189","https://openalex.org/W1953765329","https://openalex.org/W1968417548","https://openalex.org/W1978318306","https://openalex.org/W1988858173","https://openalex.org/W1997545624","https://openalex.org/W2003237988","https://openalex.org/W2004136340","https://openalex.org/W2004352153","https://openalex.org/W2006903353","https://openalex.org/W2008620284","https://openalex.org/W2011626114","https://openalex.org/W2015867005","https://openalex.org/W2018964226","https://openalex.org/W2024587809","https://openalex.org/W2041362467","https://openalex.org/W2042985281","https://openalex.org/W2043014652","https://openalex.org/W2046031771","https://openalex.org/W2056055245","https://openalex.org/W2056282083","https://openalex.org/W2059588998","https://openalex.org/W2063612092","https://openalex.org/W2065261129","https://openalex.org/W2068422015","https://openalex.org/W2074648749","https://openalex.org/W2081152882","https://openalex.org/W2084717966","https://openalex.org/W2093107388","https://openalex.org/W2098093433","https://openalex.org/W2099242535","https://openalex.org/W2101242375","https://openalex.org/W2114089215","https://openalex.org/W2117891705","https://openalex.org/W2122410886","https://openalex.org/W2127059331","https://openalex.org/W2132777822","https://openalex.org/W2140484175","https://openalex.org/W2155231169","https://openalex.org/W2158657377","https://openalex.org/W2162573823","https://openalex.org/W2169838870","https://openalex.org/W2203878617","https://openalex.org/W2325381864","https://openalex.org/W2417870322","https://openalex.org/W2494562948","https://openalex.org/W2506594678","https://openalex.org/W2748211241","https://openalex.org/W4211091071"],"related_works":["https://openalex.org/W1885821775","https://openalex.org/W4292438622","https://openalex.org/W4255659712","https://openalex.org/W4293147159","https://openalex.org/W2106109834","https://openalex.org/W1996485240","https://openalex.org/W3095525985","https://openalex.org/W2904897856","https://openalex.org/W2004725899","https://openalex.org/W2144673703"],"abstract_inverted_index":{"The":[0],"modification":[1],"of":[2,6,18],"the":[3,7],"enzymatic":[4],"activity":[5],"cytochrome":[8],"P450":[9],"(CYP)":[10],"enzymes":[11],"by":[12],"inhibition,":[13],"induction,":[14],"or":[15],"activation":[16],"is":[17],"great":[19],"interest":[20],"to":[21],"enzymologists,":[22],"pharmacologists,":[23],"and":[24],"chemists":[25],"who":[26],"are":[27],"...":[28]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":34},{"year":2023,"cited_by_count":25},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
